60 Degrees has signed a patent licence agreement with Yale School of Medicine fo...
Pharma CEOs have told EC President von der Leyen they may shift operations towar...
RFK Jr supported the MMR vaccine’s efficacy in preventing measles, but also shar...
Following the launch of the first disease-modifying therapies for Alzheimer’s di...
Rhythm's Imcivree has shown benefit in a Phase III trial in patients with acquir...
China’s NMPA has granted approval for the marketing authorisation application of...
The CMS has opted not to move forward with a plan that would have extended Medic...
The European Commission (EC) has granted approval for AstraZeneca's Imfinzi plus...
Ethris has partnered Lonza for the development of room-temperature stable mRNA v...
US policy changes to withdraw from the WHO and cut USAID have had clinical reper...
The European Commission (EC) has granted approval for the extension of indicatio...
Eisai/Biogen’s Leqembi (lecanemab) was fully approved in the US in July 2023, an...
Late-stage pipeline products anticipated to reach the uveitis market during the ...
The EC has approved Daiichi Sankyo and AstraZeneca’s Enhertu for use as a single...
This week, the Trump administration followed through on its planned mass layoffs...
Streeting said his June 10-year plan will address drug sale clawbacks, NICE regu...
